AGP Picks
View all

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on April 20, 2026

Conavi Medical Announces FDA 510(k) Clearance of its Next-Generation Hybrid IVUS-OCT System for Intravascular Imaging
Seres Therapeutics Showcases SER-155 Data and Live Biotherapeutic Insights at ESCMID Global 2026
TransAlta Appoints Mike Politeski as Chief Financial Officer and Grant Arnold as Chief Commercial Officer
Bodor Laser Ranked No. 1 in Global Sales Volume for Seven Consecutive Years, Demonstrating Brand Strength Through Sustained Leadership
ANI Pharmaceuticals Announces the FDA Approval and Launch of Pimozide Tablets with 180 Day CGT Exclusivity
Evidence Supporting Combined Use of Deucrictibant IR with Deucrictibant XR Presented at CIIC Spring 2026 Conference
JETOUR to Unveil “Travel+” Strategy at Auto China 2026
B2Gold Announces Agreement to Sell its 70% Interest in Fingold Joint Venture to Agnico Eagle for US$325 million; B2Gold and Agnico Eagle to Enter into Nunavut Collaboration Agreement
Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics
Parsons Demand Response Technology to Optimize and Enable Los Angeles Department of Water & Power’s Operations and Strategic Plan
Solera Introduces AI Engine, a Cloud-Native Intelligence Layer Powering Faster Innovation Across the Automotive Ecosystem
BOSS Zhipin's Sustained Share Repurchases Achieved Over RMB913 Million in 2026
Prelude Therapeutics Announces Pricing of $90.0 Million Underwritten Offering
CoatingSolution4U Wins Bronze at the 2026 Edison Awards in Materials Science
Equinor ASA: Notice of annual general meeting 12 May 2026
Vitaquest Highlights Quality Systems Supporting Its Responsibility to Customers and Consumers
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026
KuCoin Builds on PROOF Launch with New Competitions and Expanded Rewards of up to USD 500,000
Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026
Invitation: Q1 2026 Results Release and Conference Call - Wednesday, May 13th, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Telecoms Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.